Niclas Nilsson will become the new head of LU Innovation next week after more than 17 years with dermatology company Leo Pharma.

LU Innovation, the commercialisation arm of Lund University, is set to welcome Niclas Nilsson as its new head next week, according to News Øresund.
Nilsson will join LU Innovation from Leo Pharma, a Denmark-based dermatology company, where he had most recently served as head of R&D open innovation since 2014.
The appointment to LU Innovation marks a return to his alma mater, as Nilsson had gained his PhD in cellular and molecular biology from the institution in 2004.
During the last two years of his doctoral studies, he also worked as a researcher for spinout Hepta Helix – although there does not to be little public information about this company and it is not listed in Sweden’s company register.
– Image courtesy of LinkedIn